CareFusion — Q3 FY2012 Earnings Presentation
20 slides from CareFusion's earnings presentation, May 3, 2012
Slide 1: Q3 and 9-Months Fiscal 2012 Investor/Analyst Call
Exhibit 99.2 Q3 and 9-Months Fiscal 2012 Investor/Analyst Call May 3, 2012 © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 2: Safe Harbor and Additional Information
Safe Harbor and Additional Information “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. The
Slide 3: Today's Speakers
Today’s Speakers • Kieran Gallahue, Chairman and Chief Executive Officer • Jim Hinrichs, Chief Financial Officer © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. 3
Slide 4: Agenda
Agenda Q3 and 9-Months Fiscal 2012 Results Updated Fiscal 2012 Guidance Q&A © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. 4
Slide 5: Q3 and 9-Months Fiscal 2012 Results
Q3 and 9-Months Fiscal 2012 Results © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 6: Q3 FY12 Year-Over-Year Quarterly Review
Q3 FY12 Year-Over-Year Quarterly Review GAAP Adjusted $M % Change¹ $M % Change¹ Revenue $919 9% $919 9% Operating Expenses² ,³ $298 (3)% $286 1% Operating Income³ $161 10% $173 12% Income From Continuing $103 20% $112 19% Operations³ Diluted EPS From Continuing $0.45 18% $0.49 17% Operations³ 1 % Ch
Slide 7: Q3 FY12 Year-Over-Year Quarterly Segment Review
Q3 FY12 Year-Over-Year Quarterly Segment Review GAAP Adjusted Medical Systems $M % Change¹ $M % Change¹ Revenues $591 19% $591 19% Segment Profit² $125 29% $132 21% Procedural Solutions $M % Change¹ $M % Change¹ Revenues $328 (5)% $328 (5)% Segment Profit² $36 6% $41 (11)% 1 % Change over prior year
Slide 8: Q3 FY12 Year-Over-Year Quarterly Sub-Segment Revenues
Q3 FY12 Year-Over-Year Quarterly Sub-Segment Revenues $ in millions Q3 FY12 Q3 FY11 % Change Medical Systems $591 $498 19% Dispensing Technologies $261 $210 24% Infusion Systems $245 $213 15% Respiratory Technologies $78 $69 13% Other $7 $6 17% Procedural Solutions $328 $344 (5)% Infection Preventio
Slide 9: 9-Months FY12 Year-Over-Year Review
9-Months FY12 Year-Over-Year Review GAAP Adjusted $M % Change¹ $M % Change¹ Revenue $2,633 6% $2,633 6% Operating Expenses² ,³ $910 (3)% $880 4% Operating Income³ $414 19% $444 5% Income From Continuing $266 34% $288 13% Operations³ Diluted EPS From Continuing $1.17 33% $1.27 11% Operations³ 1 % Cha
Slide 10: 9-Months FY12 Year-Over-Year Segment Review
9-Months FY12 Year-Over-Year Segment Review GAAP Adjusted Medical Systems $M % Change¹ $M % Change¹ Revenues $1,672 12% $1,672 12% Segment Profit² $334 28% $352 14% Procedural Solutions $M % Change¹ $M % Change¹ Revenues $961 (4)% $961 (4)% Segment Profit² $80 10% $92 (19)% 1 % Change over prior yea
Slide 11: 9-Months FY12 Year-Over-Year Sub-Segment Revenues
9-Months FY12 Year-Over-Year Sub-Segment Revenues $M 9-Mo. FY12 9-Mo. FY11 % Change Medical Systems $1,672 $1,489 12% Dispensing Technologies $756 $644 17% Infusion Systems $690 $628 10% Respiratory Technologies $207 $199 4% Other $19 $18 6% Procedural Solutions $961 $1,003 (4)% Infection Prevention
Slide 12: Updated Fiscal 2012 Guidance
Updated Fiscal 2012 Guidance © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 13: Updated FY12 Financial Guidance
Updated FY12 Financial Guidance May 3, 2012 2,3 Previous FY12 Outlook¹ Updated FY12 Outlook 3-5% growth over FY11 revenue of $3.5B 4-5% growth over FY11 revenue of $3.4B Total Revenue on a constant currency basis on a constant currency basis Adjusted Operating Margin 4 ~17.1% ~17.3% Adjusted Effecti
Slide 14: FY12 Revenue and Adjusted EPS Guidance and Assumptions
FY12 Revenue and Adjusted EPS Guidance and Assumptions • Guidance O Revenue growth of 4 to 5 percent over FY11 revenues of $3.4B on a constant currency basis O Adjusted diluted EPS of $1.75 to $1.80 • Assumptions O CareFusion markets grow low single digits; expect to do better based on differentiati
Slide 15: FY12 Medical Systems Segment-Related Assumptions vs. FY11 Results
FY12 Medical Systems Segment- Related Assumptions vs. FY11 Results • Revenue grows on a percentage basis by high single digits O Dispensing Technologies: Revenue grows on a percentage basis by low to mid teens • Assumes contributions from Rowa for approximately 11 months of the year O Infusion Syste
Slide 16: FY12 Procedural Solutions Segment-Related Assumptions vs. FY11 Results
FY12 Procedural Solutions Segment- Related Assumptions vs. FY11 Results • Revenue on a percentage basis declines low single digits O Infection Prevention: Revenue grows on a percentage basis by low to mid single digits O Medical Specialties: Revenue is flat O Specialty Disposables: Revenue on a perc
Slide 17: Historical Continuing Operations Financial Highlights
Historical Continuing Operations Financial Highlights 1 GAAP FY 2010 FY 2011 FY 2012 $M FY10 Q1 FY11 Q2 FY11 Q3 FY11 Q4 FY11 FY11 Q1 FY12 Q2 FY12 Revenue $3,376 $790 $860 $842 $940 $3,432 $824 $890 Gross Margin 50.1% 51.0% 50.3% 51.9% 51.9% 51.3% 50.8% 50.1% Operating Income $450 $80 $122 $146 $149
Slide 18: Q&A
Q&A © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 19: Q3 FY12 Non-GAAP Reconciliations
Q3 FY12 Non-GAAP Reconciliations Q3 FY12 Nonrecurring Q3 FY12 $M GAAP Items¹ Adjusted¹ Operating Expenses $298 $(12) $286 Operating Income $161 $12 $173 Income From Continuing Operations $103 $9 $112 Diluted EPS From Continuing $0.45 $0.04 $0.49 Operations² Medical Systems Segment Profit $125 $7 $13
Slide 20: 9-Months FY12 Non-GAAP Reconciliations
9-Months FY12 Non-GAAP Reconciliations 9-Mo. FY12 Nonrecurring 9-Mo. FY12 $M GAAP Items¹ Adjusted¹ Operating Expenses $910 $(30) $880 Operating Income $414 $30 $444 Income From Continuing Operations $266 $22 $288 Diluted EPS From Continuing $1.17 $0.10 $1.27 Operations² Medical Systems Segment Profi